# 2026-12137: Arizona Prisons Apply to Import Execution Drug

2026-12137, Importer of Controlled Substances Application: Arizona Department of Corrections, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-06-17, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026. (as of 2026-06-24).

- Canonical: https://policyrisk.com/federal-register/2026-12137
- As of: 2026-06-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12137
- Title: Importer of Controlled Substances Application: Arizona Department of Corrections
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 36617
- Published: 2026-06-17
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 17, 2026. Such persons may also file a written request for a hearing on the application on or before July 17, 2026.
- Comments close: 2026-07-17
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-24

## In one line

Arizona Prisons Apply to Import Execution Drug

## Summary

The Arizona Department of Corrections wants to officially import a controlled drug called Pentobarbital, which is a Schedule II substance. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could affect how the state handles certain medicines, but no costs or changes for the public are expected right now.

## Abstract

Arizona Department of Corrections has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-12137 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/17/2026-12137/importer-of-controlled-substances-application-arizona-department-of-corrections)
- [2026-12137 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-17/pdf/2026-12137.pdf)

## Related
- [Previous: 2026-12136, Notice of Agreements Filed](https://policyrisk.com/federal-register/2026-12136)
- [Next: 2026-12138, Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pha…](https://policyrisk.com/federal-register/2026-12138)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12137 (as of 2026-06-24).